Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Dermatology
•
General Dermatology
In the era of targeted therapies, are there any specific cytokines that help guide therapy?
Related Questions
For hirsutism or acne, what factors or signs raise a suspicion to order a workup?
Do you pursue a cardiac evaluation in all patients with an excised cutaneous myxoma?
How do you approach treatment escalation to systemic agents for erythromelalgia, after treating with topicals and trigger avoidance?
Would you recommend continuing Accutane in a teenage female who has experienced a drop in calcium to 8.8 and reductions in albumin and protein levels one month into therapy?
Does the presence of psoriatic arthritis affect your decision to use an anti-IL-17 or IL-23 drug in your psoriasis patients?
What is your preferred workup for a patient who has a biopsy consistent with “dermal hypersensitivity reaction”?
What is your late or no-show policy for patients?
What is your treatment approach to non-uremic calciphylaxis? Which treatment modalities do you combine?
What work up do you pursue for splinter hemorrhages in an otherwise healthy patient?
How do you manage polymorphic light eruption (PMLE)?
